OPTN and amyotrophic lateral sclerosis: Inhibition of RIPK1 by Nec-1 or knock-out of RIPK3 protected against demyelination and lead to a decrease in axonal pathology hallmarks, in both a sporadic (optineurin-deficient) and familial (SOD1G93A) ALS mouse model [76].